0001567619-21-011362.txt : 20210528 0001567619-21-011362.hdr.sgml : 20210528 20210528162448 ACCESSION NUMBER: 0001567619-21-011362 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210526 FILED AS OF DATE: 20210528 DATE AS OF CHANGE: 20210528 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROBBINS LARRY CENTRAL INDEX KEY: 0001228603 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39292 FILM NUMBER: 21980577 MAIL ADDRESS: STREET 1: 767 FIFTH AVENUE STREET 2: 44TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10153 FORMER NAME: FORMER CONFORMED NAME: ROBBINS LAWRENCE M DATE OF NAME CHANGE: 20030423 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Butterfly Network, Inc. CENTRAL INDEX KEY: 0001804176 STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 530 OLD WHITFIELD STREET CITY: GUILFORD STATE: CT ZIP: 06437 BUSINESS PHONE: 203-689-5650 MAIL ADDRESS: STREET 1: 530 OLD WHITFIELD STREET CITY: GUILFORD STATE: CT ZIP: 06437 FORMER COMPANY: FORMER CONFORMED NAME: Longview Acquisition Corp. DATE OF NAME CHANGE: 20200220 4 1 doc1.xml FORM 4 X0306 4 2021-05-26 0 0001804176 Butterfly Network, Inc. BFLY 0001228603 ROBBINS LARRY 767 FIFTH AVENUE 44TH FLOOR NEW YORK NY 10153 1 0 1 0 Class A Common Stock 2021-05-26 4 P 0 150000 11.0933 A 4924846 I See footnotes Class A Common Stock 2021-05-27 4 P 0 39905 11.0963 A 4964751 I See footnotes Class A Common Stock 13157 D Class A Common Stock 10275000 I See footnotes These shares of the Issuer's Common Stock, par value $0.0001 per share (the "Shares") were purchased by Glenview Healthcare Master Fund, L.P. This price reflects the weighted average price for open-market purchases of Shares on May 26, 2021 within a $1.00 range. The actual prices for these transactions range from $11.03 to $11.13, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price. These shares were purchased by Glenview Capital Partners, L.P., Glenview Institutional Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P. and Glenview Offshore Opportunity Master Fund, Ltd. This price reflects the weighted average price for open-market purchases of Shares on May 27, 2021 within a $1.00 range. The actual prices for these transactions range from $11.06 to $11.10, inclusive. Mr. Robbins further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price. Glenview Capital Partners, L.P., Glenview Institutional Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Healthcare Master Fund, L.P. (the "Glenview Investment Funds") are the record holders of these Shares. Mr. Robbins is the Founder, Portfolio Manager and CEO of Glenview Capital Management, LLC, which serves as investment manager to each of the Glenview Investment Funds. Mr. Robbins shares voting and dispositive power over the shares held by the Glenview Investment Funds and may be deemed to beneficially own such shares. Longview Investors LLC ("Longview"), or its affiliates, is the record holder of these Shares. Mr. Robbins is the managing member of Longview. Mr. Robbins shares voting and dispositive power over the shares held by Longview and may be deemed to beneficially own such shares. Mr. Robbins disclaims beneficial ownership over any Shares owned by Longview and the Glenview Investment Funds other than to the extent of any pecuniary interest he may have therein. Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one Share upon vesting. The RSUs vest in equal annual installments over three years beginning on February 16, 2022, subject to Mr. Robbins' continued service through the applicable vesting date. Exhibit List: The Power of Attorney filed as Exhibit B to the Schedule 13G filed by Glenview Capital Management LLC on April 22, 2021 is incorporated herein by reference. /s/ Mark J. Horowitz, attorney-in-fact for Larry Robbins 2021-05-28